Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREE1 and TREE2: Oxaliplatin/Fluoropyrimidine +/- Bevacizumab in mCRC
NCT00399750Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Sanofi. Started Nov 2002; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00399750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399750.